/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
Company

FDA

85 articles decelerating

In 2026, an FDA fast track for digital-health AI and Kintsugi’s clearance failure made the agency a central gatekeeper for healthcare software.

Who they are

FDA appears in this coverage as the U.S. regulator whose clearances, authorizations, trial approvals and enforcement role determine whether consumer devices, clinical software and brain-computer interfaces can move into healthcare use. Its recurring role is especially prominent around Apple, Samsung, Google, Neuralink and smaller digital-health developers.

The recent arc

Coverage intensified in the 2024 wearable-health cycle, led by Samsung’s authorization for Galaxy Watch sleep-apnea detection and the FDA’s approval of Apple’s sleep-apnea detection across recent Apple Watch models. Apple’s AirPods Pro 2 hearing-aid feature then became a landmark story: TechCrunch described it as the first over-the-counter hearing-aid software device.

The tension

The coverage circles a persistent trade-off between accelerating health-tech innovation and preserving a credible clinical gatekeeping function. Apple, Samsung and Google have sought regulatory validation for increasingly medical smartwatch features, while Neuralink and Paradromics depend on authorization to test brain implants; Kintsugi’s shutdown after failing to obtain clearance shows that the same threshold can constrain AI-health startups.

Why it matters

If the fast-track approach to digital health continues, FDA decisions could increasingly shape which AI tools become embedded in healthcare and consumer devices, not merely which conventional medical hardware reaches patients. The unresolved question in the coverage is whether quicker pathways can widen access without weakening the evidentiary standards that distinguish medical claims from general-purpose technology.

FDA has appeared in 85 articles since 2015-03. Coverage peaked in 2024Q2 with 7 articles. Frequently mentioned alongside Apple, the Apple Watch, The Food and Drug Administration, Neuralink.

Articles
85
mentions
Velocity
-25.0%
growth rate
Acceleration
-1.250
velocity change
Sources
34
publications
Robinhood’s $156M Boom Tests Prediction-Market Trust
Robinhood reported $156M in Q2 prediction-market revenue, more than 10 times its year-earlier total and ahead of stocks and crypto, as Kalshi’s disputes exposed...

Coverage Timeline

2025-11-20
Wired 1 related

Paradromics says it received FDA approval for a human trial of its Connexus brain implant, aimed at restoring speech to those with severe motor impairments

The Austin-based startup will test its high-bandwidth device to help restore speech in people with extremely limited movement.

2025-10-16
MIT Technology Review

How AI-powered tools like PainChek, an app that scans a person's face for tiny muscle movements, are helping health care providers better assess patients' pain

For years at Orchard Care Homes, a 23‑facility dementia-care chain in northern England, Cheryl Baird watched nurses fill … X: @deenamousa , @deenamousa , @deenamousa , @deenamousa , and @deenamousa Bl...

2025-09-10
The Verge 11 related

Apple Watch's hypertension notifications and sleep score will come to some older models with watchOS 26; Apple expects FDA clearance for the notifications soon

New hypertension notifications are coming to the Watch Series 9 and up. … Apple just announced a bunch of new health-tracking …

2025-05-10
Fierce Biotech 12 related

The US FDA plans to deploy AI tools to all centers by June 30, 2025 to speed up scientific reviews, after completing a pilot and naming its first AI chief

FDA Artificial Intelligence AI and Machine Learning Biotech  —  The FDA has appointed its first chief artificial intelligence officer …

2025-04-09
9to5Google 15 related

Google rolls out Loss of Pulse Detection to the Pixel Watch 3 in the US after getting FDA clearance in February 2025; the feature rolled out in Europe in 2024

Following the April 2025 OTA update and Scam Detection yesterday, Google is now rolling out Loss of Pulse Detection in the US.

2025-02-27
9to5Google 15 related

Google says it received FDA clearance for the Pixel Watch 3's Loss of Pulse Detection feature, available in the EU and rolling out in the US at the end of March

Loss of Pulse Detection was announced last August as the Pixel Watch 3's latest safety feature, and it has finally been approved …

2024-09-16
TechCrunch 11 related

The FDA approves sleep apnea detection in the Apple Watch Series 9, Series 10, and Ultra 2, before the 10's September 20 launch, after Samsung in early 2024

The US Food and Drug Administration Monday published approval for sleep apnea detection on the Apple Watch Series 9, Series 10 and Watch Ultra 2.

2024-09-13
TechCrunch 25 related

The FDA approves the Hearing Aid Feature in Apple's AirPods Pro 2, calling it the “first over-the-counter hearing aid software device”

https://www.fda.gov/... Jeffrey P. Bigham / @jbigham@hci.social : super exciting — AirPods granted FDA approval to serve as hearing aids ... first over the counter hearing aid, enabled by a software u...

2024-09-12
TechCrunch 9 related

The FDA approves the Hearing Aid Feature in Apple's AirPods Pro 2, calling it the “first over-the-counter hearing aid software device”

Brian Heater / TechCrunch :

2024-09-10
9to5Mac 15 related

Apple debuts Apple Watch Series 10, with a thinner design, a bigger screen, smaller bezels, a Jet Black finish, faster charging, more, coming Sept. 20 for $399+

similar to the Series 9 — but they are in other regions.  Apple, however, is not advertising the O2 sensor on any page in any region. … Victoria Song / @vicmsong : Fast charging def takes the sting ou...

Loading articles...

Quarterly Coverage

Top Sources

Narrative

TEXXR tracks 90 tech news articles mentioning FDA, dating back to March 2015. The biggest stories include Neuralink says the company received US FDA approval to launch its first-in-human clinical... and The US FDA clears hypertension notifications on Apple Watch, and Apple plans to roll out.... Frequently covered alongside Apple, The US FDA, the Apple Watch, Neuralink, and The Food and Drug Administration. Coverage has shifted toward safety, research themes and away from consumer, developer.

Key Moments

2024Q2developer -5pts; consumer +25pts; funding +20pts
2024Q3consumer -20pts; funding +20pts
2025Q2developer +13pts; consumer -80pts; funding -23pts

Relationships

Loading graph...